nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ABCB1—Ethinyl Estradiol—osteoporosis	0.0786	0.133	CbGbCtD
Silodosin—CYP3A4—Estropipate—osteoporosis	0.0731	0.124	CbGbCtD
Silodosin—CYP3A4—Calcitriol—osteoporosis	0.0731	0.124	CbGbCtD
Silodosin—CYP3A4—Ergocalciferol—osteoporosis	0.0584	0.099	CbGbCtD
Silodosin—ABCB1—Conjugated Estrogens—osteoporosis	0.0577	0.0978	CbGbCtD
Silodosin—ABCB1—Estradiol—osteoporosis	0.0507	0.0859	CbGbCtD
Silodosin—CYP3A4—Raloxifene—osteoporosis	0.0488	0.0827	CbGbCtD
Silodosin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0471	0.0798	CbGbCtD
Silodosin—CYP3A4—Cholecalciferol—osteoporosis	0.0377	0.0638	CbGbCtD
Silodosin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0346	0.0586	CbGbCtD
Silodosin—CYP3A4—Estradiol—osteoporosis	0.0304	0.0514	CbGbCtD
Silodosin—Hepatobiliary disease—Risedronate—osteoporosis	0.00151	0.00434	CcSEcCtD
Silodosin—Dizziness—Calcium Acetate—osteoporosis	0.0015	0.00431	CcSEcCtD
Silodosin—Sinusitis—Risedronate—osteoporosis	0.0015	0.00431	CcSEcCtD
Silodosin—Libido decreased—Estradiol—osteoporosis	0.0015	0.0043	CcSEcCtD
Silodosin—Purpura—Estradiol—osteoporosis	0.00144	0.00413	CcSEcCtD
Silodosin—Asthenia—Ergocalciferol—osteoporosis	0.00144	0.00413	CcSEcCtD
Silodosin—Sinusitis—Pamidronate—osteoporosis	0.00142	0.00409	CcSEcCtD
Silodosin—Palpitations—Estropipate—osteoporosis	0.0014	0.00401	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Estradiol—osteoporosis	0.00138	0.00395	CcSEcCtD
Silodosin—Syncope—Raloxifene—osteoporosis	0.00137	0.00394	CcSEcCtD
Silodosin—Nausea—Calcium Acetate—osteoporosis	0.00135	0.00387	CcSEcCtD
Silodosin—Loss of consciousness—Raloxifene—osteoporosis	0.00134	0.00386	CcSEcCtD
Silodosin—Palpitations—Ibandronate—osteoporosis	0.00134	0.00385	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00134	0.00384	CcSEcCtD
Silodosin—Angiopathy—Ethinyl Estradiol—osteoporosis	0.00133	0.00383	CcSEcCtD
Silodosin—Cardiac disorder—Risedronate—osteoporosis	0.00133	0.00382	CcSEcCtD
Silodosin—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00133	0.00382	CcSEcCtD
Silodosin—Angiopathy—Risedronate—osteoporosis	0.0013	0.00374	CcSEcCtD
Silodosin—Immune system disorder—Risedronate—osteoporosis	0.0013	0.00372	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00129	0.00372	CcSEcCtD
Silodosin—Mediastinal disorder—Risedronate—osteoporosis	0.00129	0.00371	CcSEcCtD
Silodosin—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00129	0.0037	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00128	0.00368	CcSEcCtD
Silodosin—Liver function test abnormal—Estradiol—osteoporosis	0.00128	0.00368	CcSEcCtD
Silodosin—Cardiac disorder—Pamidronate—osteoporosis	0.00127	0.00363	CcSEcCtD
Silodosin—Nervous system disorder—Estropipate—osteoporosis	0.00126	0.00363	CcSEcCtD
Silodosin—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.00126	0.00363	CcSEcCtD
Silodosin—Dry mouth—Ibandronate—osteoporosis	0.00126	0.00362	CcSEcCtD
Silodosin—Mental disorder—Risedronate—osteoporosis	0.00126	0.00361	CcSEcCtD
Silodosin—Breast disorder—Estradiol—osteoporosis	0.00125	0.0036	CcSEcCtD
Silodosin—Sinusitis—Conjugated Estrogens—osteoporosis	0.00125	0.0036	CcSEcCtD
Silodosin—Skin disorder—Estropipate—osteoporosis	0.00125	0.0036	CcSEcCtD
Silodosin—Nasopharyngitis—Estradiol—osteoporosis	0.00124	0.00356	CcSEcCtD
Silodosin—Angiopathy—Pamidronate—osteoporosis	0.00124	0.00355	CcSEcCtD
Silodosin—Dry mouth—Calcitriol—osteoporosis	0.00123	0.00355	CcSEcCtD
Silodosin—Immune system disorder—Pamidronate—osteoporosis	0.00123	0.00354	CcSEcCtD
Silodosin—Mediastinal disorder—Pamidronate—osteoporosis	0.00123	0.00353	CcSEcCtD
Silodosin—Shock—Raloxifene—osteoporosis	0.00123	0.00353	CcSEcCtD
Silodosin—Nervous system disorder—Raloxifene—osteoporosis	0.00122	0.00352	CcSEcCtD
Silodosin—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00122	0.0035	CcSEcCtD
Silodosin—Shock—Ibandronate—osteoporosis	0.00122	0.00349	CcSEcCtD
Silodosin—Skin disorder—Raloxifene—osteoporosis	0.00121	0.00348	CcSEcCtD
Silodosin—Nervous system disorder—Ibandronate—osteoporosis	0.00121	0.00348	CcSEcCtD
Silodosin—Skin disorder—Ibandronate—osteoporosis	0.0012	0.00345	CcSEcCtD
Silodosin—Nausea—Ergocalciferol—osteoporosis	0.00119	0.00342	CcSEcCtD
Silodosin—Urticaria—Etidronic acid—osteoporosis	0.00118	0.0034	CcSEcCtD
Silodosin—Abdominal pain—Etidronic acid—osteoporosis	0.00118	0.00338	CcSEcCtD
Silodosin—Skin disorder—Calcitriol—osteoporosis	0.00118	0.00338	CcSEcCtD
Silodosin—Insomnia—Estropipate—osteoporosis	0.00117	0.00335	CcSEcCtD
Silodosin—Cardiac disorder—Zoledronate—osteoporosis	0.00116	0.00332	CcSEcCtD
Silodosin—Angiopathy—Zoledronate—osteoporosis	0.00113	0.00325	CcSEcCtD
Silodosin—Insomnia—Raloxifene—osteoporosis	0.00113	0.00324	CcSEcCtD
Silodosin—Immune system disorder—Zoledronate—osteoporosis	0.00112	0.00323	CcSEcCtD
Silodosin—Mediastinal disorder—Zoledronate—osteoporosis	0.00112	0.00322	CcSEcCtD
Silodosin—Syncope—Risedronate—osteoporosis	0.00112	0.00322	CcSEcCtD
Silodosin—Insomnia—Ibandronate—osteoporosis	0.00112	0.00321	CcSEcCtD
Silodosin—Gastrointestinal disorder—Estropipate—osteoporosis	0.00111	0.0032	CcSEcCtD
Silodosin—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00111	0.0032	CcSEcCtD
Silodosin—Loss of consciousness—Risedronate—osteoporosis	0.0011	0.00315	CcSEcCtD
Silodosin—Insomnia—Calcitriol—osteoporosis	0.00109	0.00314	CcSEcCtD
Silodosin—Mental disorder—Zoledronate—osteoporosis	0.00109	0.00313	CcSEcCtD
Silodosin—Angiopathy—Conjugated Estrogens—osteoporosis	0.00109	0.00312	CcSEcCtD
Silodosin—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00108	0.00311	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00108	0.00311	CcSEcCtD
Silodosin—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.00108	0.0031	CcSEcCtD
Silodosin—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00108	0.0031	CcSEcCtD
Silodosin—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00107	0.00307	CcSEcCtD
Silodosin—Syncope—Pamidronate—osteoporosis	0.00106	0.00306	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00106	0.00303	CcSEcCtD
Silodosin—Pruritus—Etidronic acid—osteoporosis	0.00105	0.00303	CcSEcCtD
Silodosin—Gastrointestinal pain—Estropipate—osteoporosis	0.00105	0.00303	CcSEcCtD
Silodosin—Mental disorder—Conjugated Estrogens—osteoporosis	0.00105	0.00302	CcSEcCtD
Silodosin—Loss of consciousness—Pamidronate—osteoporosis	0.00104	0.003	CcSEcCtD
Silodosin—Jaundice—Estradiol—osteoporosis	0.00104	0.00299	CcSEcCtD
Silodosin—Dry mouth—Risedronate—osteoporosis	0.00104	0.00299	CcSEcCtD
Silodosin—Gastrointestinal pain—Alendronate—osteoporosis	0.00104	0.00298	CcSEcCtD
Silodosin—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00102	0.00294	CcSEcCtD
Silodosin—Urticaria—Estropipate—osteoporosis	0.00102	0.00294	CcSEcCtD
Silodosin—Gastrointestinal pain—Raloxifene—osteoporosis	0.00102	0.00293	CcSEcCtD
Silodosin—Diarrhoea—Etidronic acid—osteoporosis	0.00102	0.00293	CcSEcCtD
Silodosin—Abdominal pain—Estropipate—osteoporosis	0.00102	0.00293	CcSEcCtD
Silodosin—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00102	0.00292	CcSEcCtD
Silodosin—Hepatobiliary disease—Estradiol—osteoporosis	0.00101	0.0029	CcSEcCtD
Silodosin—Gastrointestinal pain—Ibandronate—osteoporosis	0.00101	0.0029	CcSEcCtD
Silodosin—Urticaria—Alendronate—osteoporosis	0.00101	0.0029	CcSEcCtD
Silodosin—Abdominal pain—Alendronate—osteoporosis	0.001	0.00288	CcSEcCtD
Silodosin—Sinusitis—Estradiol—osteoporosis	0.001	0.00288	CcSEcCtD
Silodosin—Shock—Risedronate—osteoporosis	0.001	0.00288	CcSEcCtD
Silodosin—Nervous system disorder—Risedronate—osteoporosis	0.000999	0.00287	CcSEcCtD
Silodosin—Skin disorder—Risedronate—osteoporosis	0.00099	0.00284	CcSEcCtD
Silodosin—Gastrointestinal pain—Calcitriol—osteoporosis	0.00099	0.00284	CcSEcCtD
Silodosin—Abdominal pain—Raloxifene—osteoporosis	0.000987	0.00284	CcSEcCtD
Silodosin—Urticaria—Ibandronate—osteoporosis	0.000982	0.00282	CcSEcCtD
Silodosin—Abdominal pain—Ibandronate—osteoporosis	0.000977	0.00281	CcSEcCtD
Silodosin—Syncope—Zoledronate—osteoporosis	0.000972	0.00279	CcSEcCtD
Silodosin—Urticaria—Calcitriol—osteoporosis	0.000961	0.00276	CcSEcCtD
Silodosin—Palpitations—Zoledronate—osteoporosis	0.000958	0.00275	CcSEcCtD
Silodosin—Abdominal pain—Calcitriol—osteoporosis	0.000957	0.00275	CcSEcCtD
Silodosin—Shock—Pamidronate—osteoporosis	0.000953	0.00274	CcSEcCtD
Silodosin—Loss of consciousness—Zoledronate—osteoporosis	0.000953	0.00274	CcSEcCtD
Silodosin—Nervous system disorder—Pamidronate—osteoporosis	0.00095	0.00273	CcSEcCtD
Silodosin—Tachycardia—Pamidronate—osteoporosis	0.000945	0.00272	CcSEcCtD
Silodosin—Rash—Etidronic acid—osteoporosis	0.00094	0.0027	CcSEcCtD
Silodosin—Dermatitis—Etidronic acid—osteoporosis	0.000939	0.0027	CcSEcCtD
Silodosin—Syncope—Conjugated Estrogens—osteoporosis	0.000936	0.00269	CcSEcCtD
Silodosin—Headache—Etidronic acid—osteoporosis	0.000934	0.00268	CcSEcCtD
Silodosin—Asthenia—Estropipate—osteoporosis	0.000925	0.00266	CcSEcCtD
Silodosin—Palpitations—Conjugated Estrogens—osteoporosis	0.000922	0.00265	CcSEcCtD
Silodosin—Insomnia—Risedronate—osteoporosis	0.000922	0.00265	CcSEcCtD
Silodosin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000917	0.00264	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000917	0.00263	CcSEcCtD
Silodosin—Pruritus—Estropipate—osteoporosis	0.000912	0.00262	CcSEcCtD
Silodosin—Asthenia—Alendronate—osteoporosis	0.000911	0.00262	CcSEcCtD
Silodosin—Hypotension—Pamidronate—osteoporosis	0.000905	0.0026	CcSEcCtD
Silodosin—Dry mouth—Zoledronate—osteoporosis	0.000903	0.00259	CcSEcCtD
Silodosin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000902	0.00259	CcSEcCtD
Silodosin—Pruritus—Alendronate—osteoporosis	0.000898	0.00258	CcSEcCtD
Silodosin—Cardiac disorder—Estradiol—osteoporosis	0.000891	0.00256	CcSEcCtD
Silodosin—Asthenia—Ibandronate—osteoporosis	0.000887	0.00255	CcSEcCtD
Silodosin—Nausea—Etidronic acid—osteoporosis	0.000885	0.00254	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000883	0.00253	CcSEcCtD
Silodosin—Diarrhoea—Estropipate—osteoporosis	0.000882	0.00253	CcSEcCtD
Silodosin—Gastrointestinal disorder—Risedronate—osteoporosis	0.00088	0.00253	CcSEcCtD
Silodosin—Insomnia—Pamidronate—osteoporosis	0.000876	0.00252	CcSEcCtD
Silodosin—Pruritus—Ibandronate—osteoporosis	0.000875	0.00251	CcSEcCtD
Silodosin—Angiopathy—Estradiol—osteoporosis	0.000871	0.0025	CcSEcCtD
Silodosin—Shock—Zoledronate—osteoporosis	0.00087	0.0025	CcSEcCtD
Silodosin—Diarrhoea—Alendronate—osteoporosis	0.000869	0.0025	CcSEcCtD
Silodosin—Asthenia—Calcitriol—osteoporosis	0.000868	0.00249	CcSEcCtD
Silodosin—Nervous system disorder—Zoledronate—osteoporosis	0.000868	0.00249	CcSEcCtD
Silodosin—Immune system disorder—Estradiol—osteoporosis	0.000867	0.00249	CcSEcCtD
Silodosin—Mediastinal disorder—Estradiol—osteoporosis	0.000865	0.00248	CcSEcCtD
Silodosin—Tachycardia—Zoledronate—osteoporosis	0.000863	0.00248	CcSEcCtD
Silodosin—Skin disorder—Zoledronate—osteoporosis	0.000859	0.00247	CcSEcCtD
Silodosin—Pruritus—Calcitriol—osteoporosis	0.000856	0.00246	CcSEcCtD
Silodosin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000855	0.00245	CcSEcCtD
Silodosin—Diarrhoea—Raloxifene—osteoporosis	0.000855	0.00245	CcSEcCtD
Silodosin—Dizziness—Estropipate—osteoporosis	0.000853	0.00245	CcSEcCtD
Silodosin—Diarrhoea—Ibandronate—osteoporosis	0.000846	0.00243	CcSEcCtD
Silodosin—Mental disorder—Estradiol—osteoporosis	0.000841	0.00241	CcSEcCtD
Silodosin—Dizziness—Alendronate—osteoporosis	0.00084	0.00241	CcSEcCtD
Silodosin—Shock—Conjugated Estrogens—osteoporosis	0.000838	0.00241	CcSEcCtD
Silodosin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000836	0.0024	CcSEcCtD
Silodosin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000835	0.0024	CcSEcCtD
Silodosin—Gastrointestinal pain—Risedronate—osteoporosis	0.000833	0.00239	CcSEcCtD
Silodosin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000831	0.00239	CcSEcCtD
Silodosin—Urticaria—Ethinyl Estradiol—osteoporosis	0.00083	0.00238	CcSEcCtD
Silodosin—Diarrhoea—Calcitriol—osteoporosis	0.000828	0.00238	CcSEcCtD
Silodosin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000827	0.00238	CcSEcCtD
Silodosin—Hypotension—Zoledronate—osteoporosis	0.000827	0.00237	CcSEcCtD
Silodosin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000826	0.00237	CcSEcCtD
Silodosin—Dizziness—Raloxifene—osteoporosis	0.000826	0.00237	CcSEcCtD
Silodosin—Dizziness—Ibandronate—osteoporosis	0.000818	0.00235	CcSEcCtD
Silodosin—Rash—Estropipate—osteoporosis	0.000813	0.00233	CcSEcCtD
Silodosin—Dermatitis—Estropipate—osteoporosis	0.000812	0.00233	CcSEcCtD
Silodosin—Urticaria—Risedronate—osteoporosis	0.000809	0.00232	CcSEcCtD
Silodosin—Headache—Estropipate—osteoporosis	0.000808	0.00232	CcSEcCtD
Silodosin—Abdominal pain—Risedronate—osteoporosis	0.000805	0.00231	CcSEcCtD
Silodosin—Rash—Alendronate—osteoporosis	0.000801	0.0023	CcSEcCtD
Silodosin—Insomnia—Zoledronate—osteoporosis	0.0008	0.0023	CcSEcCtD
Silodosin—Dermatitis—Alendronate—osteoporosis	0.0008	0.0023	CcSEcCtD
Silodosin—Hypotension—Conjugated Estrogens—osteoporosis	0.000796	0.00229	CcSEcCtD
Silodosin—Headache—Alendronate—osteoporosis	0.000796	0.00229	CcSEcCtD
Silodosin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000792	0.00227	CcSEcCtD
Silodosin—Rash—Raloxifene—osteoporosis	0.000787	0.00226	CcSEcCtD
Silodosin—Dermatitis—Raloxifene—osteoporosis	0.000787	0.00226	CcSEcCtD
Silodosin—Headache—Raloxifene—osteoporosis	0.000782	0.00225	CcSEcCtD
Silodosin—Rash—Ibandronate—osteoporosis	0.00078	0.00224	CcSEcCtD
Silodosin—Dermatitis—Ibandronate—osteoporosis	0.000779	0.00224	CcSEcCtD
Silodosin—Headache—Ibandronate—osteoporosis	0.000775	0.00222	CcSEcCtD
Silodosin—Insomnia—Conjugated Estrogens—osteoporosis	0.000771	0.00221	CcSEcCtD
Silodosin—Nausea—Estropipate—osteoporosis	0.000766	0.0022	CcSEcCtD
Silodosin—Abdominal pain—Pamidronate—osteoporosis	0.000766	0.0022	CcSEcCtD
Silodosin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000764	0.00219	CcSEcCtD
Silodosin—Rash—Calcitriol—osteoporosis	0.000763	0.00219	CcSEcCtD
Silodosin—Dermatitis—Calcitriol—osteoporosis	0.000762	0.00219	CcSEcCtD
Silodosin—Headache—Calcitriol—osteoporosis	0.000758	0.00218	CcSEcCtD
Silodosin—Nausea—Alendronate—osteoporosis	0.000754	0.00217	CcSEcCtD
Silodosin—Asthenia—Ethinyl Estradiol—osteoporosis	0.00075	0.00215	CcSEcCtD
Silodosin—Syncope—Estradiol—osteoporosis	0.000749	0.00215	CcSEcCtD
Silodosin—Nausea—Raloxifene—osteoporosis	0.000742	0.00213	CcSEcCtD
Silodosin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000739	0.00212	CcSEcCtD
Silodosin—Palpitations—Estradiol—osteoporosis	0.000738	0.00212	CcSEcCtD
Silodosin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000735	0.00211	CcSEcCtD
Silodosin—Nausea—Ibandronate—osteoporosis	0.000734	0.00211	CcSEcCtD
Silodosin—Loss of consciousness—Estradiol—osteoporosis	0.000734	0.00211	CcSEcCtD
Silodosin—Asthenia—Risedronate—osteoporosis	0.000731	0.0021	CcSEcCtD
Silodosin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000723	0.00208	CcSEcCtD
Silodosin—Pruritus—Risedronate—osteoporosis	0.000721	0.00207	CcSEcCtD
Silodosin—Nausea—Calcitriol—osteoporosis	0.000719	0.00206	CcSEcCtD
Silodosin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000715	0.00205	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000706	0.00203	CcSEcCtD
Silodosin—Urticaria—Zoledronate—osteoporosis	0.000703	0.00202	CcSEcCtD
Silodosin—Abdominal pain—Zoledronate—osteoporosis	0.000699	0.00201	CcSEcCtD
Silodosin—Diarrhoea—Risedronate—osteoporosis	0.000697	0.002	CcSEcCtD
Silodosin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000697	0.002	CcSEcCtD
Silodosin—Dry mouth—Estradiol—osteoporosis	0.000696	0.002	CcSEcCtD
Silodosin—Asthenia—Pamidronate—osteoporosis	0.000695	0.002	CcSEcCtD
Silodosin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000691	0.00198	CcSEcCtD
Silodosin—Pruritus—Pamidronate—osteoporosis	0.000685	0.00197	CcSEcCtD
Silodosin—Urticaria—Conjugated Estrogens—osteoporosis	0.000677	0.00194	CcSEcCtD
Silodosin—Dizziness—Risedronate—osteoporosis	0.000674	0.00194	CcSEcCtD
Silodosin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000673	0.00193	CcSEcCtD
Silodosin—Shock—Estradiol—osteoporosis	0.000671	0.00193	CcSEcCtD
Silodosin—Nervous system disorder—Estradiol—osteoporosis	0.000669	0.00192	CcSEcCtD
Silodosin—Tachycardia—Estradiol—osteoporosis	0.000665	0.00191	CcSEcCtD
Silodosin—Diarrhoea—Pamidronate—osteoporosis	0.000663	0.0019	CcSEcCtD
Silodosin—Skin disorder—Estradiol—osteoporosis	0.000662	0.0019	CcSEcCtD
Silodosin—Rash—Ethinyl Estradiol—osteoporosis	0.000659	0.00189	CcSEcCtD
Silodosin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000658	0.00189	CcSEcCtD
Silodosin—Headache—Ethinyl Estradiol—osteoporosis	0.000655	0.00188	CcSEcCtD
Silodosin—Rash—Risedronate—osteoporosis	0.000642	0.00185	CcSEcCtD
Silodosin—Dermatitis—Risedronate—osteoporosis	0.000642	0.00184	CcSEcCtD
Silodosin—Dizziness—Pamidronate—osteoporosis	0.000641	0.00184	CcSEcCtD
Silodosin—Headache—Risedronate—osteoporosis	0.000638	0.00183	CcSEcCtD
Silodosin—Asthenia—Zoledronate—osteoporosis	0.000635	0.00182	CcSEcCtD
Silodosin—Pruritus—Zoledronate—osteoporosis	0.000626	0.0018	CcSEcCtD
Silodosin—Nausea—Ethinyl Estradiol—osteoporosis	0.000621	0.00178	CcSEcCtD
Silodosin—Insomnia—Estradiol—osteoporosis	0.000617	0.00177	CcSEcCtD
Silodosin—Asthenia—Conjugated Estrogens—osteoporosis	0.000611	0.00176	CcSEcCtD
Silodosin—Rash—Pamidronate—osteoporosis	0.000611	0.00175	CcSEcCtD
Silodosin—Dermatitis—Pamidronate—osteoporosis	0.00061	0.00175	CcSEcCtD
Silodosin—Headache—Pamidronate—osteoporosis	0.000607	0.00174	CcSEcCtD
Silodosin—Diarrhoea—Zoledronate—osteoporosis	0.000605	0.00174	CcSEcCtD
Silodosin—Nausea—Risedronate—osteoporosis	0.000605	0.00174	CcSEcCtD
Silodosin—Pruritus—Conjugated Estrogens—osteoporosis	0.000603	0.00173	CcSEcCtD
Silodosin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000589	0.00169	CcSEcCtD
Silodosin—Dizziness—Zoledronate—osteoporosis	0.000585	0.00168	CcSEcCtD
Silodosin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000583	0.00167	CcSEcCtD
Silodosin—Nausea—Pamidronate—osteoporosis	0.000575	0.00165	CcSEcCtD
Silodosin—Dizziness—Conjugated Estrogens—osteoporosis	0.000563	0.00162	CcSEcCtD
Silodosin—Rash—Zoledronate—osteoporosis	0.000558	0.0016	CcSEcCtD
Silodosin—Gastrointestinal pain—Estradiol—osteoporosis	0.000558	0.0016	CcSEcCtD
Silodosin—Dermatitis—Zoledronate—osteoporosis	0.000557	0.0016	CcSEcCtD
Silodosin—Headache—Zoledronate—osteoporosis	0.000554	0.00159	CcSEcCtD
Silodosin—Urticaria—Estradiol—osteoporosis	0.000542	0.00156	CcSEcCtD
Silodosin—Abdominal pain—Estradiol—osteoporosis	0.000539	0.00155	CcSEcCtD
Silodosin—Rash—Conjugated Estrogens—osteoporosis	0.000537	0.00154	CcSEcCtD
Silodosin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000537	0.00154	CcSEcCtD
Silodosin—Headache—Conjugated Estrogens—osteoporosis	0.000534	0.00153	CcSEcCtD
Silodosin—Nausea—Zoledronate—osteoporosis	0.000526	0.00151	CcSEcCtD
Silodosin—Nausea—Conjugated Estrogens—osteoporosis	0.000506	0.00145	CcSEcCtD
Silodosin—Asthenia—Estradiol—osteoporosis	0.000489	0.00141	CcSEcCtD
Silodosin—Pruritus—Estradiol—osteoporosis	0.000482	0.00139	CcSEcCtD
Silodosin—Diarrhoea—Estradiol—osteoporosis	0.000467	0.00134	CcSEcCtD
Silodosin—Dizziness—Estradiol—osteoporosis	0.000451	0.0013	CcSEcCtD
Silodosin—Rash—Estradiol—osteoporosis	0.00043	0.00123	CcSEcCtD
Silodosin—Dermatitis—Estradiol—osteoporosis	0.00043	0.00123	CcSEcCtD
Silodosin—Headache—Estradiol—osteoporosis	0.000427	0.00123	CcSEcCtD
Silodosin—Nausea—Estradiol—osteoporosis	0.000405	0.00116	CcSEcCtD
Silodosin—ADRA1B—GPCR ligand binding—PTHLH—osteoporosis	0.000119	0.00193	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—TGFB1—osteoporosis	0.000117	0.0019	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—WNT1—osteoporosis	0.000117	0.0019	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.000115	0.00186	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000112	0.00182	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—MGLL—osteoporosis	0.000112	0.00181	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SOST—osteoporosis	0.000111	0.00179	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—MTHFR—osteoporosis	0.000111	0.00179	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—MGLL—osteoporosis	0.000109	0.00177	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—PTHLH—osteoporosis	0.000106	0.00172	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CALCA—osteoporosis	0.000105	0.0017	CbGpPWpGaD
Silodosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	0.000105	0.0017	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—IDH2—osteoporosis	0.000103	0.00167	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTH1R—osteoporosis	0.0001	0.00162	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CALCR—osteoporosis	0.0001	0.00162	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—MGLL—osteoporosis	9.94e-05	0.00161	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PTH—osteoporosis	9.82e-05	0.00159	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP27A1—osteoporosis	9.67e-05	0.00157	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CNR2—osteoporosis	9.57e-05	0.00155	CbGpPWpGaD
Silodosin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.52e-05	0.00154	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	9.52e-05	0.00154	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ACP5—osteoporosis	9.41e-05	0.00152	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CALCA—osteoporosis	9.34e-05	0.00151	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—IL1B—osteoporosis	9.21e-05	0.00149	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SOST—osteoporosis	9.2e-05	0.00149	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PTH—osteoporosis	8.91e-05	0.00144	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—POMC—osteoporosis	8.85e-05	0.00143	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	8.81e-05	0.00143	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—TPI1—osteoporosis	8.75e-05	0.00142	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	8.71e-05	0.00141	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CNR2—osteoporosis	8.69e-05	0.00141	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	8.46e-05	0.00137	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTH1R—osteoporosis	8.32e-05	0.00135	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CALCR—osteoporosis	8.32e-05	0.00135	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—P4HB—osteoporosis	8.23e-05	0.00133	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SOST—osteoporosis	8.17e-05	0.00132	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—WNT1—osteoporosis	8.17e-05	0.00132	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PTH—osteoporosis	8.15e-05	0.00132	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PTHLH—osteoporosis	8.13e-05	0.00132	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GAPDH—osteoporosis	8.07e-05	0.00131	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MGLL—osteoporosis	7.96e-05	0.00129	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CNR2—osteoporosis	7.94e-05	0.00128	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—RAP1A—osteoporosis	7.86e-05	0.00127	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LRP5—osteoporosis	7.77e-05	0.00126	CbGpPWpGaD
Silodosin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.72e-05	0.00125	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LRP6—osteoporosis	7.43e-05	0.0012	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PTH—osteoporosis	7.4e-05	0.0012	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTH1R—osteoporosis	7.39e-05	0.0012	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CALCR—osteoporosis	7.39e-05	0.0012	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PTHLH—osteoporosis	7.39e-05	0.0012	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PTH—osteoporosis	7.24e-05	0.00117	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.23e-05	0.00117	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CNR2—osteoporosis	7.21e-05	0.00117	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—CALCA—osteoporosis	7.16e-05	0.00116	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—TGFB1—osteoporosis	7.15e-05	0.00116	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CNR2—osteoporosis	7.05e-05	0.00114	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	6.82e-05	0.0011	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	6.8e-05	0.0011	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—WNT1—osteoporosis	6.78e-05	0.0011	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PTHLH—osteoporosis	6.75e-05	0.00109	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	6.73e-05	0.00109	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—TNF—osteoporosis	6.68e-05	0.00108	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—POMC—osteoporosis	6.63e-05	0.00107	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MGLL—osteoporosis	6.61e-05	0.00107	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PTH—osteoporosis	6.57e-05	0.00106	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CALCA—osteoporosis	6.5e-05	0.00105	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LRP5—osteoporosis	6.45e-05	0.00104	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.42e-05	0.00104	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CNR2—osteoporosis	6.4e-05	0.00104	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ENO1—osteoporosis	6.36e-05	0.00103	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PKM—osteoporosis	6.28e-05	0.00102	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—FDPS—osteoporosis	6.28e-05	0.00102	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TLN1—osteoporosis	6.28e-05	0.00102	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PSMA2—osteoporosis	6.26e-05	0.00101	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PSMA5—osteoporosis	6.26e-05	0.00101	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LRP6—osteoporosis	6.17e-05	0.000999	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PTHLH—osteoporosis	6.13e-05	0.000992	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—WNT1—osteoporosis	6.02e-05	0.000974	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PTHLH—osteoporosis	6e-05	0.00097	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PGLS—osteoporosis	5.95e-05	0.000963	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPD2—osteoporosis	5.95e-05	0.000963	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CALCA—osteoporosis	5.94e-05	0.000962	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.89e-05	0.000953	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MGLL—osteoporosis	5.87e-05	0.00095	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LRP5—osteoporosis	5.73e-05	0.000927	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—POMC—osteoporosis	5.5e-05	0.000891	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LRP6—osteoporosis	5.48e-05	0.000887	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PTHLH—osteoporosis	5.45e-05	0.000881	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PNP—osteoporosis	5.44e-05	0.000881	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ATIC—osteoporosis	5.44e-05	0.000881	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—P4HB—osteoporosis	5.41e-05	0.000876	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CALCA—osteoporosis	5.4e-05	0.000873	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CALCA—osteoporosis	5.28e-05	0.000854	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTH—osteoporosis	5.27e-05	0.000852	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TLN1—osteoporosis	5.21e-05	0.000843	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RAP1A—osteoporosis	5.17e-05	0.000837	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CNR2—osteoporosis	5.13e-05	0.00083	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	5.11e-05	0.000827	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—ADCY5—osteoporosis	5.09e-05	0.000824	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP19A1—osteoporosis	5.08e-05	0.000822	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NFATC1—osteoporosis	5.05e-05	0.000817	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—DKK1—osteoporosis	5.01e-05	0.000811	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—POMC—osteoporosis	4.89e-05	0.000791	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—WNT1—osteoporosis	4.82e-05	0.000781	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CALCA—osteoporosis	4.79e-05	0.000776	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FGA—osteoporosis	4.69e-05	0.00076	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CA2—osteoporosis	4.63e-05	0.000749	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—OXCT1—osteoporosis	4.63e-05	0.000749	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TLN1—osteoporosis	4.63e-05	0.000749	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ADCY5—osteoporosis	4.63e-05	0.000749	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MGLL—osteoporosis	4.51e-05	0.00073	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—P4HB—osteoporosis	4.49e-05	0.000727	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTH—osteoporosis	4.37e-05	0.000707	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTHLH—osteoporosis	4.36e-05	0.000706	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—BMP2—osteoporosis	4.36e-05	0.000706	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RAP1A—osteoporosis	4.3e-05	0.000695	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FGB—osteoporosis	4.27e-05	0.000691	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CNR2—osteoporosis	4.26e-05	0.000689	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.24e-05	0.000686	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ADCY5—osteoporosis	4.23e-05	0.000684	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NFATC1—osteoporosis	4.19e-05	0.000678	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—DKK1—osteoporosis	4.16e-05	0.000673	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ADCY5—osteoporosis	4.15e-05	0.000672	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GPX1—osteoporosis	4.14e-05	0.00067	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PSMA2—osteoporosis	4.12e-05	0.000667	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PSMA5—osteoporosis	4.12e-05	0.000667	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—POMC—osteoporosis	4.1e-05	0.000664	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—WNT1—osteoporosis	4e-05	0.000648	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—P4HB—osteoporosis	3.99e-05	0.000646	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FGA—osteoporosis	3.9e-05	0.00063	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTH—osteoporosis	3.88e-05	0.000628	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PKM—osteoporosis	3.87e-05	0.000626	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—FDPS—osteoporosis	3.87e-05	0.000626	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CALCA—osteoporosis	3.84e-05	0.000622	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	3.84e-05	0.000621	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—IDH2—osteoporosis	3.84e-05	0.000621	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—MTHFR—osteoporosis	3.82e-05	0.000618	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RAP1A—osteoporosis	3.82e-05	0.000617	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CNR2—osteoporosis	3.78e-05	0.000612	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	3.77e-05	0.00061	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—ADCY5—osteoporosis	3.76e-05	0.000608	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—POMC—osteoporosis	3.75e-05	0.000606	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NFATC1—osteoporosis	3.72e-05	0.000602	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—DKK1—osteoporosis	3.69e-05	0.000598	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPD2—osteoporosis	3.67e-05	0.000593	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PGLS—osteoporosis	3.67e-05	0.000593	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	3.62e-05	0.000586	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—BMP2—osteoporosis	3.62e-05	0.000586	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP27A1—osteoporosis	3.61e-05	0.000584	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—WNT1—osteoporosis	3.56e-05	0.000576	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FGB—osteoporosis	3.54e-05	0.000574	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.54e-05	0.000573	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.53e-05	0.000571	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ACP5—osteoporosis	3.51e-05	0.000568	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KL—osteoporosis	3.49e-05	0.000565	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FGA—osteoporosis	3.46e-05	0.00056	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	3.42e-05	0.000554	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	3.42e-05	0.000554	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	3.41e-05	0.000552	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—POMC—osteoporosis	3.4e-05	0.000551	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ATIC—osteoporosis	3.35e-05	0.000543	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PNP—osteoporosis	3.35e-05	0.000543	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6R—osteoporosis	3.32e-05	0.000537	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.3e-05	0.000535	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	3.3e-05	0.000533	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TPI1—osteoporosis	3.26e-05	0.000528	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—BMP2—osteoporosis	3.22e-05	0.000521	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	3.22e-05	0.000521	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CALCA—osteoporosis	3.19e-05	0.000516	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FGB—osteoporosis	3.15e-05	0.000509	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	3.11e-05	0.000503	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—P4HB—osteoporosis	3.07e-05	0.000496	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—POMC—osteoporosis	3.05e-05	0.000494	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	3.04e-05	0.000492	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	3.04e-05	0.000492	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GAPDH—osteoporosis	3.01e-05	0.000487	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—RAP1A—osteoporosis	2.93e-05	0.000474	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KL—osteoporosis	2.9e-05	0.000469	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA2—osteoporosis	2.85e-05	0.000462	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—OXCT1—osteoporosis	2.85e-05	0.000462	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CALCA—osteoporosis	2.83e-05	0.000458	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—POMC—osteoporosis	2.82e-05	0.000457	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MGLL—osteoporosis	2.78e-05	0.00045	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	2.76e-05	0.000447	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	2.75e-05	0.000446	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	2.73e-05	0.000442	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SPP1—osteoporosis	2.64e-05	0.000428	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KL—osteoporosis	2.57e-05	0.000416	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—POMC—osteoporosis	2.51e-05	0.000406	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	2.45e-05	0.000396	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS2—osteoporosis	2.39e-05	0.000387	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ENO1—osteoporosis	2.37e-05	0.000383	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—IDH2—osteoporosis	2.36e-05	0.000382	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—LEP—osteoporosis	2.34e-05	0.000379	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSMA2—osteoporosis	2.34e-05	0.000378	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSMA5—osteoporosis	2.34e-05	0.000378	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	2.27e-05	0.000367	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ESR1—osteoporosis	2.23e-05	0.000361	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.22e-05	0.00036	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SPP1—osteoporosis	2.19e-05	0.000355	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ACP5—osteoporosis	2.16e-05	0.00035	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS1—osteoporosis	2.09e-05	0.000338	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	2.01e-05	0.000326	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—POMC—osteoporosis	2.01e-05	0.000325	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TPI1—osteoporosis	2.01e-05	0.000325	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS2—osteoporosis	1.98e-05	0.000321	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6R—osteoporosis	1.96e-05	0.000317	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SPP1—osteoporosis	1.95e-05	0.000315	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LEP—osteoporosis	1.94e-05	0.000314	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF1—osteoporosis	1.93e-05	0.000313	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP19A1—osteoporosis	1.89e-05	0.000307	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—P4HB—osteoporosis	1.89e-05	0.000306	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GAPDH—osteoporosis	1.85e-05	0.0003	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.85e-05	0.0003	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—RAP1A—osteoporosis	1.81e-05	0.000292	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS2—osteoporosis	1.76e-05	0.000285	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.73e-05	0.00028	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LEP—osteoporosis	1.72e-05	0.000279	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.67e-05	0.00027	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ESR1—osteoporosis	1.65e-05	0.000266	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.63e-05	0.000263	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.6e-05	0.00026	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ADCY5—osteoporosis	1.55e-05	0.00025	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPX1—osteoporosis	1.54e-05	0.00025	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS1—osteoporosis	1.54e-05	0.000249	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—POMC—osteoporosis	1.48e-05	0.00024	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—osteoporosis	1.48e-05	0.000239	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ENO1—osteoporosis	1.46e-05	0.000236	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6R—osteoporosis	1.45e-05	0.000234	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSMA2—osteoporosis	1.44e-05	0.000233	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSMA5—osteoporosis	1.44e-05	0.000233	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1—osteoporosis	1.43e-05	0.000231	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—osteoporosis	1.42e-05	0.00023	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.23e-05	0.000199	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.17e-05	0.000189	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—osteoporosis	1.16e-05	0.000188	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	1.16e-05	0.000188	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—POMC—osteoporosis	1.14e-05	0.000184	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—osteoporosis	1.09e-05	0.000176	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—osteoporosis	9.64e-06	0.000156	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	9.62e-06	0.000156	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADCY5—osteoporosis	9.54e-06	0.000154	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX1—osteoporosis	9.5e-06	0.000154	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—osteoporosis	8.77e-06	0.000142	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—osteoporosis	8.73e-06	0.000141	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—osteoporosis	8.57e-06	0.000139	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	8.54e-06	0.000138	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—osteoporosis	7.25e-06	0.000117	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—POMC—osteoporosis	7.01e-06	0.000114	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—osteoporosis	6.44e-06	0.000104	CbGpPWpGaD
